News Releases Year None202120202019 Feb 16, 2021 Immunovant Reports Financial Results for the Quarter and Nine Months Ended December 31, 2020 Feb 02, 2021 Immunovant Announces Voluntary Pause in Clinical Dosing of IMVT-1401 Jan 12, 2021 Immunovant Appoints Rita Jain Chief Medical Officer And Provides Corporate Update
Feb 16, 2021 Immunovant Reports Financial Results for the Quarter and Nine Months Ended December 31, 2020
